1. Home
  2. ABEO
  3. ABEO News

Latest Abeona Therapeutics Inc. (ABEO) News on September 4, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) About To Shift From Loss To Profit
ABEO

Simply Wall St.

2 months ago

Abeona Therapeutics Inc. (NASDAQ:ABEO) About To Shift From Loss To Profit

ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
ABEO

GlobeNewswire

2 months ago

ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
ABEO

PR Newswire

2 months ago

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
ABEO

GlobeNewswire

2 months ago

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

3 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
ABEO

GlobeNewswire

3 months ago

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

ABEO

Zacks Small Cap Research

4 months ago

ABEO: Sells Priority Review Voucher for $155 Million…

ABEO

Associated Press Finance

4 months ago

Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

4 months ago

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

Abeona secures cash runway with $155m priority review voucher sale
ABEO

Pharmaceutical Technology

4 months ago

Abeona secures cash runway with $155m priority review voucher sale

ABEO

MT Newswires

4 months ago

Abeona Therapeutics to Sell Zevaskyn Priority Review Voucher for $155 Million; Shares Rise

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

Abeona sells speedy drug review voucher for $155M
ABEO

BioPharma Dive

4 months ago

Abeona sells speedy drug review voucher for $155M

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

4 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FDA approves Abeona’s $3.1m cell therapy for rare skin disease
ABEO

Pharmaceutical Technology

4 months ago

FDA approves Abeona’s $3.1m cell therapy for rare skin disease

ABEO

Zacks Small Cap Research

4 months ago

ABEO: Zevaskyn™ Approved by FDA; Raising Valuation to $11…

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
ABEO

Benzinga

4 months ago

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy

ABEO

MT Newswires

4 months ago

Abeona Therapeutics Says US FDA Approves Zevaskyn to Treat Wounds in Patients With Genetic Skin Disease

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
ABEO

GlobeNewswire

4 months ago

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

5 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

5 months ago

ABEO: Countdown to PDUFA Date of April 29, 2025…

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
ABEO

GuruFocus.com

5 months ago

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

ABEO

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Abeona Therapeutics Inc Earnings Call

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
ABEO

GlobeNewswire

5 months ago

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
ABEO

GlobeNewswire

6 months ago

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

Abeona Therapeutics announces new employee inducement grants
ABEO

TipRanks

6 months ago

Abeona Therapeutics announces new employee inducement grants

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

6 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit
ABEO

Simply Wall St.

7 months ago

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

7 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

8 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),
ABEO

Simply Wall St.

8 months ago

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

9 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

ACCESSWIRE

9 months ago

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ABEO

Zacks Small Cap Research

10 months ago

ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
ABEO

GuruFocus.com

10 months ago

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

ABEO

Associated Press Finance

10 months ago

Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics® Announces Participation in November Investor Conferences
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Announces Participation in November Investor Conferences

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
ABEO

GlobeNewswire

10 months ago

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...
ABEO

GuruFocus.com

a year ago

Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

a year ago

ABEO: Type A Meeting with FDA Concluded; BLA Submission on Track for 2H24…

Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors

Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel

ABEO

MT Newswires

a year ago

Abeona Therapeutics Shares Jump After Q2 Loss Narrows

ABEO

Associated Press Finance

a year ago

Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)
ABEO

Simply Wall St.

a year ago

Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies

Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications

Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
ABEO

GuruFocus.com

a year ago

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Files for $300 Million Mixed Shelf, $75 Million At-The-Market Offering

ABEO

Business Wire

a year ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains
ABEO

AFP

a year ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock
ABEO

Motley Fool

a year ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
ABEO

GlobeNewswire

a year ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
ABEO

GlobeNewswire

a year ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

3 Major Product Releases at 3Shape Discover Event
ABEO

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation
ABEO

PR Newswire

a year ago

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

Pioneering Progress, Shaping Tomorrow: SUPCON Global Product Launch Conference 2024 Held in Singapore
ABEO

PR Newswire

a year ago

Pioneering Progress, Shaping Tomorrow: SUPCON Global Product Launch Conference 2024 Held in Singapore

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

MT Newswires

a year ago

Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

ABEO

Zacks Small Cap Research

a year ago

ABEO: BLA Resubmission in 2H24

ABEO

GuruFocus.com

a year ago

Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...

ABEO

Thomson Reuters StreetEvents

a year ago

Q1 2024 Abeona Therapeutics Inc Earnings Call

ABEO

Associated Press Finance

a year ago

Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

MT Newswires

a year ago

Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

ABEO

Zacks Small Cap Research

a year ago

ABEO: Receives CRL Based on Need for More CMC Information…

ABEO

MT Newswires

a year ago

Top Midday Decliners

ABEO

MT Newswires

a year ago

Top Premarket Decliners

FDA rejects Abeona cell therapy, asks for more manufacturing data
ABEO

BioPharma Dive

a year ago

FDA rejects Abeona cell therapy, asks for more manufacturing data

ABEO

MT Newswires

a year ago

Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval

ABEO

Reuters

a year ago

UPDATE 1-US FDA declines to approve Abeona's skin disorder treatment

ABEO

Reuters

a year ago

US FDA declines to approve Abeona's skin disorder treatment

Abeona Therapeutics Provides Regulatory Update on Pz-cel
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
ABEO

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results
ABEO

GuruFocus.com

a year ago

Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

Several Insiders Invested In Abeona Therapeutics Flagging Positive News
ABEO

Simply Wall St.

a year ago

Several Insiders Invested In Abeona Therapeutics Flagging Positive News

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

a year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc
ABEO

GuruFocus.com

2 years ago

Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc

Individual investors in Abeona Therapeutics Inc. (NASDAQ:ABEO) are its biggest bettors, and their bets paid off as stock gained 45% last week
ABEO

Simply Wall St.

2 years ago

Individual investors in Abeona Therapeutics Inc. (NASDAQ:ABEO) are its biggest bettors, and their bets paid off as stock gained 45% last week

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO

GlobeNewswire

2 years ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO

Zacks Small Cap Research

2 years ago

ABEO: FDA BIMO Inspection and BLA Mid-Cycle Review Complete…

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
ABEO

GlobeNewswire

2 years ago

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

Arbe Chipset Empowers HiRain's LRR610 4D Imaging Radar Systems Set for Mass Production by the End of 2024
ABEO

PR Newswire

2 years ago

Arbe Chipset Empowers HiRain's LRR610 4D Imaging Radar Systems Set for Mass Production by the End of 2024

Share on Social Networks: